🚨SAVE THE DATE FOR #DHS2024 🚨
Drug Hypersensitivity Symposium - Challenging Practice (27-29 Oct 24)
➡️Rego 30th May 2024
➡️Program: https://t.co/aBVno7aPBK
➡️🌐drug allergy gurus @vumc_cdsi_rsch @JonnyPeter7@AnaCopaescu@neilthepcist @LouiseSavic @allisoncramsey & regional ⭐️
#OnMyMind: Given questionable evidence for race-based ACE inhibitor guidelines, Peter et al strongly urge global experts to reconsider their recommendations around ACE inhibitor use in Africans with #hypertension@ntobekon@JonnyPeter7#AHAJournals https://t.co/lW2NNVccqc
🙏 to my cardiology colleagues @ntobekon and Mpiko Ntsekhe for co-authoring this piece challenging existing dogma. Hopefully we can contribute to addressing the evidence gaps in diverse African populations. #hypertension#ACEinhibitors https://t.co/NUuchjixnZ
@JonnyPeter7#AAAAI24 colleague giving a tour through #SCAR pathogenesis in 20’ ⏰… 😓 👏
Sharing new RNAseq data showing CD8+ T cell populations/TCRs from blister fluid….aka liquid gold!
@TrubianoJason@KimberlyBlumen1@VanderbiltU @Jamie_L_Waldron It is not my interest in #drugallergy that has waned rather my activity on #X. Think it is the bird watcher in me that is disappointed to not see the cute little bird no more 😢
Results from a ground-breaking pollen-monitoring study led by Prof @JonnyPeter7 revealed the importance of developing a formal, nationwide pollen-monitoring system to assist clinicians in treating patients with asthma, hayfever and eczema.
Read more: https://t.co/Z1HpDM0mjs.
Our latest study is live on @medrxivpreprint
https://t.co/uWb4PuJzU7
We asked why some (unvaccinated) individuals remain asymptomatic after SARS-CoV-2 infection, using 3 large cohorts.
And learned a lot on HLA & role in chronic phase of infection vs. acute phase
Check 🧵
Lovely to hear from valedictory colleague Dr C Du Toit about the history of #HSCT and HLA discovery in 1968. Amazing to think how far we have come with this in just over five decades! @SAImmunology
Stevens-Johnson syndrome and toxic epidermal necrolysis–associated dysgeusia: Natural history and association with dysosmia - The Journal of Allergy and Clinical Immunology: In Practice https://t.co/yKRMGfDjSK
Really great to see these issues being raised @JACIInPractice They now need to be followed by increased financial support across research, clinical services and industry sectors if we are to change these usually entrenched determinants.
After a year of revisions and hardwork, I feel very proud to share our publication on 2-years of #pollen-monitoring data from seven South African cities. This is the largest modern #aerobiological sample in the history of the country and the continent. A real team effort!👏
Our growing SA pollen network is a diverse team of aerobiologists, paleoecologists, ecologists, air quality scientist and doctors (allergists and ENT) that provide data to @realpollencount and https://t.co/HRY3bumCqO
Fantastic to highlight #Urticariaday2023 to colleagues at our allergy Congress this morning and then have an inspiring patient meeting to launch #CRUSE app for chronic urticaria disease monitor. Great steps forward to improve access to care in #SA @UrticariaDay @UCARE_4U
The ideal lecture for cross-talk between #immunologists and #allergists - Sabelo Hadebe talking about conditional mice KO of IL-4a and dissecting the impact of this receptor in different immune subsets in an #AD model #ALLSASAIS2023@SAImmunology 👏